All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Amino Acid Injection | NCIT_C15509 | [A concentrated dietary supplement for injection containing the essential amino acids leucine, isoleucine, lysine, valine, phenylalanine, histidine, threonine, methionine and tryptophan as well as the non-essential amino acids alanine, arginine, glycine, proline, serine and tyrosine, with potential anabolic and anti-catabolic activities. Upon dilution and intravenous infusion of the amino acid nutritional supplement, the amino acids serve as protein building blocks, promote protein synthesis in muscle cells and prevent protein breakdown.] |
| Grade 4 Tracheal Mucositis, CTCAE | NCIT_C146151 | [Life-threatening consequences; urgent intervention indicated] |
| Tracheal Mucositis, CTCAE | NCIT_C143881 | [A disorder characterized by an inflammation or ulceration involving the mucous membrane of the trachea.] |
| Grade 4 Tracheal Obstruction, CTCAE | NCIT_C146152 | [Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)] |
| Tracheal Obstruction, CTCAE | NCIT_C143882 | [A disorder characterized by blockage of the lumen of the trachea.] |
| Grade 4 Tracheal Stenosis, CTCAE | NCIT_C146153 | [Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)] |
| Tracheal Stenosis, CTCAE | NCIT_C143883 | [A disorder characterized by a narrowing of the trachea.] |
| Grade 4 Tracheitis, CTCAE | NCIT_C146154 | [Life-threatening consequences; urgent intervention indicated] |
| Tracheitis, CTCAE | NCIT_C143884 | [A disorder characterized by an infectious process involving the trachea.] |
| Grade 4 Tracheostomy Site Bleeding, CTCAE | NCIT_C146155 | [Life-threatening consequences; urgent intervention indicated] |
| Tracheostomy Site Bleeding, CTCAE | NCIT_C143885 | [A disorder characterized by bleeding from the tracheostomy site.] |
| Grade 4 Treatment Related Secondary Malignancy, CTCAE | NCIT_C146156 | [Acute life-threatening secondary malignancy; blast crisis in leukemia] |
| Treatment Related Secondary Malignancy, CTCAE | NCIT_C143887 | [A disorder characterized by development of a malignancy most probably as a result of treatment for a previously existing malignancy.] |
| Grade 4 Tricuspid Valve Disease, CTCAE | NCIT_C146157 | [Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)] |
| Tricuspid Valve Disease, CTCAE | NCIT_C143889 | [A disorder characterized by a defect in tricuspid valve function or structure.] |
| Grade 4 Tumor Hemorrhage, CTCAE | NCIT_C146158 | [Life-threatening consequences; urgent intervention indicated] |
| Tumor Hemorrhage, CTCAE | NCIT_C143229 | [A disorder characterized by bleeding in a tumor.] |
| Prior Endocrine Therapy for Advanced Disease | NCIT_C15512 | |
| Grade 4 Tumor Lysis Syndrome, CTCAE | NCIT_C146159 | [Life-threatening consequences; urgent intervention indicated] |
| Tumor Lysis Syndrome, CTCAE 5.0 | NCIT_C146688 | [A disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells.] |